A further 26,852 cases were confirmed across the UK. The figures came as the Moderna vaccine was approved for use in children aged 12 to 17. It was already approved in adults and is the second jab to have its authorisation extended to older children, after the Pfizer vaccine.
Dr June Raine, chief executive of the MHRA medical regulator, said: “The vaccine is safe and effective in this age group.
“We have in place a comprehensive safety surveillance strategy for monitoring the safety of all UK-approved Covid-19 vaccines, and this surveillance will include the 12 to 17-year age group.
“It is for the Joint Committee on Vaccination and Immunisation to advise on whether this age group should be vaccinated with the Covid-19 vaccine made by Moderna.”
The decision comes two weeks after the committee recommended that 16 and 17-year-olds should be offered a jab before they return to school.
Latest data shows more than 47.3 million people have received a first vaccination, including 40.8 million who have had both doses.
Separate figures from the Office for National Statistics showed that in the week to August 6, around one in 20 deaths was linked to the virus in England and Wales.
Covid was mentioned on 527 death certificates – 5.2 percent of the total.
The number of virus deaths was up 30 percent week on week and stood at its highest level since the week to March 26.
However, levels were still well below the peak of the second wave, when there were more than 8,000 deaths linked to the virus in a single week.